Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96–07
…, K Carson, A O'Neill, SA Grossman, J Alavi… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: A multicenter, phase II study of single-agent, intravenous methotrexate in newly
diagnosed non-AIDS-related primary CNS lymphoma was conducted in the New Approaches …
diagnosed non-AIDS-related primary CNS lymphoma was conducted in the New Approaches …
Positron emission tomography in patients with glioma a predictor of prognosis
JB Alavi, A Alavi, J Chawluk, M Kushner, J Powe… - Cancer, 1988 - Wiley Online Library
Positron emission tomography (PET) studies have been performed using 18‐F‐fluorodeoxyglucose
in 29 adult subjects with primary brain tumors. Seventy‐two percent of the patients …
in 29 adult subjects with primary brain tumors. Seventy‐two percent of the patients …
A randomized clinical trial of granulocyte transfusions for infection in acute leukemia
JB Alavi, RK Root, I Djerassi, AE Evans… - … England Journal of …, 1977 - Mass Medical Soc
In a prospective, controlled, randomized study to evaluate the efficacy of filtration-leukapheresis
granulocytes in granulocytopenic, febrile patients with leukemia, 19 patients received …
granulocytes in granulocytopenic, febrile patients with leukemia, 19 patients received …
Positron emission tomography imaging of regional cerebral glucose metabolism
A Alavi, R Dann, J Chawluk, J Alavi, M Kushner… - Seminars in nuclear …, 1986 - Elsevier
The (F-18) fluorodeoxyglucose (FDG) technique to measure local cerebral metabolic rate for
glucose (LCMRglu) is well accepted and widely used by many institutions around the world. …
glucose (LCMRglu) is well accepted and widely used by many institutions around the world. …
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma
…, KA Carson, P New, S Phuphanich, JB Alavi… - Neuro …, 2005 - academic.oup.com
Penicillamine is an oral agent used to treat intracerebral copper overload in Wilson's disease.
Copper is a known regulator of angiogenesis; copper reduction inhibits experimental …
Copper is a known regulator of angiogenesis; copper reduction inhibits experimental …
Treatment of Advanced CNS Malignancies with the Recombinant Adenovirus H5. 010RSVTK: A Phase I Trial. University of Pennsylvania Medical Center, Philadelphia
I. Abstract Primary CNS malignancies are responsible for approximately 12,000 deaths
annually in the United States. There has been little change in the outcome for adults with …
annually in the United States. There has been little change in the outcome for adults with …
[PDF][PDF] Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET
M Kushner, M Tobin, A Alavi, J Chawluk… - Journal of Nuclear …, 1987 - Soc Nuclear Med
METHODS The study group included: unilateral cerebral infarction— 23 (mean age 65 yr,
range 47-80 yr), unilateral cerebral tumor— 23 (mean age 52 yr, range 37-71 yr), …
range 47-80 yr), unilateral cerebral tumor— 23 (mean age 52 yr, range 37-71 yr), …
Multi‐institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high‐grade gliomas
…, YKK Cheung, PG Fisher, J Alavi… - … Journal of the …, 2008 - Wiley Online Library
BACKGROUND. The prognosis for patients with recurrent high‐grade gliomas is poor and
treatment options are limited. Current chemotherapeutic regimens can improve clinical …
treatment options are limited. Current chemotherapeutic regimens can improve clinical …
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-α delivered as a 21-day continuous intravenous infusion in …
SA Grossman, JB Alavi, JG Supko, KA Carson… - Neuro …, 2005 - academic.oup.com
Protein kinase C alpha (PKC-α) is a cytoplasmic serine threonine kinase involved in regulating
cell differentiation and proliferation. Aprinocarsen is an antisense oligonucleotide against …
cell differentiation and proliferation. Aprinocarsen is an antisense oligonucleotide against …
[PDF][PDF] PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain
CA Buchpiguel, JB Alavi, A Alavi… - Journal of Nuclear …, 1995 - Soc Nuclear Med
A 30-yr-old right-handed male noted abnormal sensation in his right foot in 1991. A bone
spur was removed surgically, but there was no symptom relief. A complete clinical and …
spur was removed surgically, but there was no symptom relief. A complete clinical and …